NO300769B1 - Heksahydronaftalenesterderivater og farmasöytiske preparater inneholdende disse - Google Patents

Heksahydronaftalenesterderivater og farmasöytiske preparater inneholdende disse Download PDF

Info

Publication number
NO300769B1
NO300769B1 NO940309A NO940309A NO300769B1 NO 300769 B1 NO300769 B1 NO 300769B1 NO 940309 A NO940309 A NO 940309A NO 940309 A NO940309 A NO 940309A NO 300769 B1 NO300769 B1 NO 300769B1
Authority
NO
Norway
Prior art keywords
group
acid
hydroxy
methyl
reaction
Prior art date
Application number
NO940309A
Other languages
English (en)
Norwegian (no)
Other versions
NO940309L (no
NO940309D0 (no
Inventor
Sadao Ishihara
Hiroshi Kogen
Teiichiro Koga
Eiichi Kitazawa
Nobufusa Serizawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO940309D0 publication Critical patent/NO940309D0/no
Publication of NO940309L publication Critical patent/NO940309L/no
Publication of NO300769B1 publication Critical patent/NO300769B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C07C69/736—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
NO940309A 1993-01-29 1994-01-28 Heksahydronaftalenesterderivater og farmasöytiske preparater inneholdende disse NO300769B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1306393 1993-01-29

Publications (3)

Publication Number Publication Date
NO940309D0 NO940309D0 (no) 1994-01-28
NO940309L NO940309L (no) 1994-08-01
NO300769B1 true NO300769B1 (no) 1997-07-21

Family

ID=11822687

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940309A NO300769B1 (no) 1993-01-29 1994-01-28 Heksahydronaftalenesterderivater og farmasöytiske preparater inneholdende disse

Country Status (21)

Country Link
US (1) US5491167A (cs)
EP (1) EP0609058B1 (cs)
JP (1) JPH06279280A (cs)
KR (1) KR100293335B1 (cs)
CN (1) CN1070487C (cs)
AT (1) ATE174324T1 (cs)
AU (1) AU664323B2 (cs)
CA (1) CA2114450A1 (cs)
CZ (1) CZ285658B6 (cs)
DE (1) DE69415050T2 (cs)
DK (1) DK0609058T3 (cs)
ES (1) ES2126057T3 (cs)
FI (1) FI940424A7 (cs)
HU (1) HU221852B1 (cs)
IL (1) IL108432A (cs)
NO (1) NO300769B1 (cs)
NZ (1) NZ250771A (cs)
PH (1) PH31662A (cs)
RU (1) RU2114101C1 (cs)
TW (1) TW411337B (cs)
ZA (1) ZA94548B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ250609A (en) * 1992-12-28 1995-07-26 Sankyo Co Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
US6043064A (en) * 1993-10-22 2000-03-28 Bristol-Myers Squibb Company Enzymatic hydroxylation process for the preparation of HMG-CoA reductase inhibitors and intermediates thereof
US5942423A (en) * 1995-06-07 1999-08-24 Massachusetts Institute Of Technology Conversion of compactin to pravastatin by actinomadura
HUP9902352A1 (hu) * 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására
MY127609A (en) * 2000-08-07 2006-12-29 Novartis Ag Process for preparing discodermolide and analogues thereof
DK1317419T3 (da) * 2000-09-06 2009-06-15 Emisphere Tech Inc Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
JP3236282B1 (ja) * 2000-10-16 2001-12-10 三共株式会社 プラバスタチンを精製する方法
RU2217141C1 (ru) * 2002-11-20 2003-11-27 Балавадзе Михаил Элизбарович Состав "витализин-1" для профилактики атеросклероза, сердечно-сосудистых заболеваний и поддерживающей терапии вирусных заболеваний
CL2008001205A1 (es) 2007-04-27 2008-11-14 Actelion Pharmaceuticals Ltd Compuestos derivados de biciclo[2.2.2]octeno; composicion farmaceutica que los contiene; y uso en el tratamiento o prevencion de angina cronica estable, hipertension, isquemia renal y cardiaca, arritmias cardiacas, hipertrofia cardiaca y falla congestiva del corazon.

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
JPS57185275A (en) * 1981-05-07 1982-11-15 Sankyo Co Ltd Tetrahydro-dum-4 and tetrahydro-isodum-4 and their derivatives
JPS5889191A (ja) * 1981-11-20 1983-05-27 Sankyo Co Ltd ３−ヒドロキシ−ｍｌ−２３６ｂ誘導体の製造法
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4876279A (en) * 1986-05-05 1989-10-24 Merck & Co., Inc. Antihypercholesterolemic compounds
US4937263A (en) * 1986-05-05 1990-06-26 Merck & Co., Inc. Antihypercholesterolemic compounds
US4937264A (en) * 1986-05-05 1990-06-26 Merck & Co., Inc. Antihypercholesterolemic compounds
US4902709A (en) * 1987-03-17 1990-02-20 Merck & Co., Inc. Novel antihypercholesterolemic compounds
US4885314A (en) * 1987-06-29 1989-12-05 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4997848A (en) * 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
US4946864A (en) * 1988-02-01 1990-08-07 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US5021453A (en) * 1988-03-02 1991-06-04 Merck & Co., Inc. 3-keto HMG-CoA reductase inhibitors
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
US4963538A (en) * 1988-06-29 1990-10-16 Merck & Co., Inc. 5-oxygenated HMG-CoA reductase inhibitors
US5130306A (en) * 1989-03-13 1992-07-14 Merck & Co., Inc. 5-Oxygenated HMG-COA reductase inhibitors
US5010105A (en) * 1989-06-09 1991-04-23 Merck & Co., Inc. Antihypercholesterolemic compounds
US5102911A (en) * 1989-06-09 1992-04-07 Merck & Co, Inc. 4-Substituted HMG-CoA reductase inhibitors
DE69008277D1 (de) * 1989-08-31 1994-05-26 Merck & Co Inc 7-Subsituierte HMG-CoA-Reduktase-Inhibitoren.

Also Published As

Publication number Publication date
AU5472894A (en) 1994-08-04
CA2114450A1 (en) 1994-07-30
KR940018352A (ko) 1994-08-16
ATE174324T1 (de) 1998-12-15
PH31662A (en) 1999-01-12
IL108432A (en) 1997-09-30
NO940309L (no) 1994-08-01
CN1098099A (zh) 1995-02-01
TW411337B (en) 2000-11-11
IL108432A0 (en) 1994-04-12
EP0609058A2 (en) 1994-08-03
FI940424A7 (fi) 1994-11-07
DK0609058T3 (da) 1999-08-16
HUT67740A (en) 1995-04-28
DE69415050T2 (de) 1999-08-12
CZ285658B6 (cs) 1999-10-13
DE69415050D1 (de) 1999-01-21
NZ250771A (en) 1995-07-26
FI940424A0 (fi) 1994-01-28
RU2114101C1 (ru) 1998-06-27
CN1070487C (zh) 2001-09-05
US5491167A (en) 1996-02-13
ES2126057T3 (es) 1999-03-16
NO940309D0 (no) 1994-01-28
ZA94548B (en) 1994-08-29
KR100293335B1 (ko) 2001-09-17
JPH06279280A (ja) 1994-10-04
EP0609058A3 (en) 1995-04-19
AU664323B2 (en) 1995-11-09
HK1011678A1 (en) 1999-07-16
HU221852B1 (hu) 2003-02-28
HU9400242D0 (en) 1994-05-30
CZ18694A3 (en) 1995-03-15
EP0609058B1 (en) 1998-12-09

Similar Documents

Publication Publication Date Title
US5451688A (en) Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses
US5187074A (en) Method of hydroxylation with ATCC 55086
US8404870B2 (en) ((2S,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)methyl carboxylate and process for the production thereof
NO300769B1 (no) Heksahydronaftalenesterderivater og farmasöytiske preparater inneholdende disse
US5260447A (en) Polyhydroxycyclopentane derivatives, their preparation and their therapeutic use
KR0177840B1 (ko) 콜레스테롤 생합성 억제를 위한 옥타히드로나프탈렌 옥심 유도체 및 그의 제법
KR20070076549A (ko) 광학적으로 활성인 사이클로펜텐온의 제조방법 및 그로부터제조된 사이클로펜텐온
EP1811037B1 (en) Optically active cyclopentenones for use in the peparation of prostaglandins
EP0480624A1 (en) Inhibitors of HIV protease
WO2007097336A1 (ja) （２ｒ，３ｒ）および（２ｓ，３ｓ）－３－フェニルイソセリン誘導体の製造法
D’Antona et al. A novel chemo-multienzymatic synthesis of bioactive cyclophellitol and epi-cyclophellitol in both enantiopure forms
HK1000937B (en) Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees